Kate J. Reilley

Statistics

Publications

Citations

297

H-Index

Active since

2010

Affiliations

Torrey Pines Institute For Molecular Studies(Current)

University of Kansas

Creighton University

Kate J. Reilley is an author at Torrey Pines Institute For Molecular Studies specializing in pharmacology, opioid receptor agonists, and opioid pharmacology.

Publications per year

2010–2013

Publications

Novel opioid cyclic tetrapeptides: Trp isomers of CJ‐15,208 exhibit distinct opioid receptor agonism and short‐acting κ opioid receptor antagonism

Nicolette C. Ross, Kate J. Reilley, Thomas F. Murray et al. · British Journal of Pharmacology · 2011 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Identification of Two Novel, Potent, Low-Liability Antinociceptive Compounds from the Direct In Vivo Screening of a Large Mixture-Based Combinatorial Library

Kate J. Reilley, Marc A. Giulianotti, Colette T. Dooley et al. · The AAPS Journal · 2010 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

The macrocyclic tetrapeptide [<scp>D</scp>‐<scp>T</scp>rp]<scp>CJ</scp>‐15,208 produces short‐acting κ opioid receptor antagonism in the<scp>CNS</scp>after oral administration

Shainnel O. Eans, Michelle L. Ganno, Kate J. Reilley et al. · British Journal of Pharmacology · 2013 · 42 citations · Full text

Medicine, Pharmacology, Behavioral Pharmacology +15

Unexpected Opioid Activity Profiles of Analogues of the Novel Peptide Kappa Opioid Receptor Ligand CJ‐15,208

Jane V. Aldrich, Santosh S. Kulkarni, Sanjeewa N. Senadheera et al. · ChemMedChem · 2011 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment

Jason J. Paris, Kate J. Reilley · Journal of Addiction Research & Therapy · 2012 · 32 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–5 of 8